M28 Capital Management LP Long-Term Concentrated

Location: Stamford, CT

CIK: 0001807489 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value: $89.2M (100.0% shares, 0.0% debt)

Holdings (13)

WVE WAVE LIFE SCIENCES LTD 30.2%

Value $26.92M Shares 8,282,204 Est. Cost $3.07 Unrealized -37.3%

IVVD ADAGIO THERAPEUTICS INC 23.5%

Value $20.99M Shares 6,398,250 Est. Cost $23.72 Unrealized -86.8%

RCKT ROCKET PHARMACEUTICALS INC 11.0%

Value $9.851M Shares 715,880 Est. Cost $24.20 Unrealized -50.7%

STOK STOKE THERAPEUTICS INC 7.8%

Value $6.964M Shares 527,150 Est. Cost $23.86 Unrealized -36.3%

BBIO BRIDGEBIO PHARMA INC 4.7%

Value $4.233M Shares 466,200 Est. Cost $42.31 Unrealized -80.2%

— CURIS INC 4.7%

Value $4.178M Shares 4,243,293 Est. Cost $3.84 Unrealized —

— MIRATI THERAPEUTICS INC 4.6%

Value $4.108M Shares 61,200 Est. Cost $97.15 Unrealized —

TGTX TG THERAPEUTICS INC 3.5%

Value $3.086M Shares 726,200 Est. Cost $18.81 Unrealized -66.8%

— LEAP THERAPEUTICS INC 3.4%

Value $3.064M Shares 2,664,400 Est. Cost $2.31 Unrealized —

— VERVE THERAPEUTICS INC 3.1%

Value $2.727M Shares 178,500 Est. Cost $22.82 Unrealized —

— ATARA BIOTHERAPEUTICS INC 2.4%

Value $2.097M Shares 269,253 Est. Cost $15.76 Unrealized —

PRQR PROQR THERAPEUTICS N V 0.9%

Value $779K Shares 1,001,800 Est. Cost $3.35 Unrealized -77.7%

— NEXIMMUNE INC 0.2%

Value $215K Shares 133,442 Est. Cost $4.61 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
WVE	WAVE LIFE SCIENCES LTD	8,282,204	$26.92M	30.2%	$3.07	-37.3%	SHS	Y95308105
IVVD	ADAGIO THERAPEUTICS INC	6,398,250	$20.99M	23.5%	$23.72	-86.8%	COM	00534A102
RCKT	ROCKET PHARMACEUTICALS INC	715,880	$9.851M	11.0%	$24.20	-50.7%	COM	77313F106
STOK	STOKE THERAPEUTICS INC	527,150	$6.964M	7.8%	$23.86	-36.3%	COM	86150R107
BBIO	BRIDGEBIO PHARMA INC	466,200	$4.233M	4.7%	$42.31	-80.2%	COM	10806X102
—	CURIS INC	4,243,293	$4.178M	4.7%	$3.84	—	COM NEW	231269200
—	MIRATI THERAPEUTICS INC	61,200	$4.108M	4.6%	$97.15	—	COM	60468T105
TGTX	TG THERAPEUTICS INC	726,200	$3.086M	3.5%	$18.81	-66.8%	COM	88322Q108
—	LEAP THERAPEUTICS INC	2,664,400	$3.064M	3.4%	$2.31	—	COM	52187K101
—	VERVE THERAPEUTICS INC	178,500	$2.727M	3.1%	$22.82	—	COM	92539P101
—	ATARA BIOTHERAPEUTICS INC	269,253	$2.097M	2.4%	$15.76	—	COM	046513107
PRQR	PROQR THERAPEUTICS N V	1,001,800	$779K	0.9%	$3.35	-77.7%	SHS EURO	N71542109
—	NEXIMMUNE INC	133,442	$215K	0.2%	$4.61	—	COM	65344D109